Please provide your email address to receive an email when new articles are posted on . Up to 88% of sentinel lymph node biopsies (SNLB) return with a negative result. The DecisionDx-Melanoma test, ...

Patients identified as low risk by DecisionDx-Melanoma had a 2.8% sentinel lymph node (SLN) positivity rate, well below the National Comprehensive Cancer Network® (NCCN) guidelines’ 5% threshold to ...

ROCHESTER, Minn. — A genomic test co-developed by Mayo Clinic and SkylineDx can identify whether people with melanoma are at low or high risk for cancer in their lymph nodes — a finding that could ...

The primary way to diagnose lymphoma involves a lymph node biopsy. However, doctors may utilize several other diagnostic procedures depending on a person’s lymphoma. Doctors can use blood tests, ...

Colon cancer treatment is personalized based on stage, overall health and tumor characteristics. Early detection and accurate ...

TAMPA, Fla. (Oct. 22, 2025) — A large multicenter clinical trial published in JAMA Surgery shows that a gene expression profile–based test can reliably identify melanoma patients who have a low risk ...

You have more than 300 lymph nodes in your head and neck. Cancer can either start in these lymph nodes or spread there from other body parts. Symptoms include swelling, fever, and night sweats. Share ...

The National Institute for Health and Clinical Excellence (NICE) is producing guidance on using the RD-100i OSNA system and the Metasin test in the NHS in England. The Diagnostics Advisory Committee ...

Systemic therapy for sarcoidosis is reserved for organ-threatening disease, and laryngeal involvement necessitates treatment ...